跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
再普乐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Olanzapine Tablets
Approved
化学药品
Olanzapine Tablets
Cheplapharm Registration GmbH
🇨🇳 National Medical Products Administration
Approval Date
May 20, 2020
Approval ID
7MazXbPZWXg
Company
Cheplapharm Registration GmbH
Type
化学药品
Approval Details
Approval Id
7MazXbPZWXg
Approval Number
H20160496
Generic Name
奥氮平片
Generic Name En
Olanzapine Tablets
Trade Name
再普乐
Brand Name
再普乐
Drug Type
化学药品
Dosage Form
片剂
Strength
5mg
Reg Date
2020-05-20
Expired Date
2025-05-19
Company Name
Cheplapharm Registration GmbH
Company Address
Weiler Straße 5e, 79540 Lörrach, Germany
Production Company Name
Lilly Del Caribe, Inc.
Production Company Address
da. de la Industria 30, 28108 Alcobendas, Madrid, Spain(PR)00985
Company Detail Path
/organization/cheplapharm-registration-gmbh
Production Company Detail Path
/organization/lilly-del-caribe-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 20, 2020
Approval ID
7MazXbPZWXg
Type
化学药品
Back to NMPA Approvals